Gastrointestinal side effects of etoricoxib in patients with osteoarthritis: results of the Etoricoxib versus Diclofenac Sodium Gastrointestinal Tolerability and Effectiveness (EDGE) trial. - Concepedia

Concepedia

Publication | Closed Access

Gastrointestinal side effects of etoricoxib in patients with osteoarthritis: results of the Etoricoxib versus Diclofenac Sodium Gastrointestinal Tolerability and Effectiveness (EDGE) trial.

80

Citations

0

References

2007

Year

Herbert S. B. Baraf, Carlos Fuentealba, Maria Greenwald, Jan Brzezicki, Katherine O’Brien, Beth A. Soffer, Adam B. Polis, Steven Bird, Amarjot Kaur, Sean Curtis

Abstract

Treatment with etoricoxib 90 mg was associated with significantly better GI tolerability compared to diclofenac in this population of patients with OA. Etoricoxib 90 mg, a dose 50% higher than indicated for OA, resulted in more discontinuations due to hypertension-related AE.